Skip to content

IEMbase 0155: DHODH-related Miller syndrome

Scope

Field Value
IEMbase ID 155
Nosology 16.1.02.01
Gene DHODH
External IDs OMIM:263750; OMIM:126064; ORPHA:246
Generated mapping UNMAPPED
Candidate DisMech targets Pyruvate_Dehydrogenase_Deficiency.yaml
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents this as DHODH-related dihydroorotate dehydrogenase deficiency, with alternate labels postaxial acrofacial dysostosis, Miller syndrome, Genee-Wiedemann syndrome, and POADS. Treatability is marked unknown.

The biochemical rows report increased urinary dihydro-orotic acid and orotic acid, with variable orotidine and N-carbamyl aspartate. The clinical signal is a congenital malformation syndrome: cleft lip/palate, micrognathia, malar hypoplasia, cup-shaped and low-set ears, conductive deafness, coloboma, postaxial limb hypoplasia or absence of fifth digits, syndactyly, radioulnar synostosis, rib defects, supernumerary vertebrae, hip dislocation, renal anomalies, cryptorchidism, micropenis, midgut malrotation, pyloric stenosis, pectus excavatum, and accessory nipples.

DisMech phenotype coverage

There is no valid local Miller syndrome / DHODH disease entry.

Pyruvate_Dehydrogenase_Deficiency.yaml is a false candidate. It is centered on PDH-complex genes, impaired pyruvate oxidation, lactic acidosis, Leigh-like neurologic disease, and ketogenic or thiamine-directed management. It does not model DHODH, de novo pyrimidine synthesis, dihydroorotate accumulation, or the postaxial acrofacial dysostosis phenotype bundle.

Some existing developmental-patterning modules may eventually help represent the craniofacial and limb malformation logic, but there is no current disease target for this entity.

Concordance and completeness

Judgement: true local gap.

The IEMbase entry is clearly anchored on DHODH and a congenital craniofacial, limb, rib, renal, and genital malformation syndrome. The generated pyruvate dehydrogenase candidate shares broad metabolic wording but not identity, mechanism, biomarkers, or phenotype structure.

Curation actions

  • Leave IEMbase 155 unmapped for now.
  • Future curation should create a DHODH/Miller syndrome entry rather than fold this into PDH deficiency.
  • Preserve the IEMbase urinary dihydro-orotic acid/orotic acid biomarkers and the serial craniofacial-limb malformation pattern as primary leads.